至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Upregulated microRNA-381-5p strengthens the effect of dexmedetomidine preconditioning to protect against myocardial ischemia-reperfusion injury in mouse models by inhibiting CHI3L1

Int Immunopharmacol. 2021-01; 
Yanan Deng, Liang Cai, Fang Wang, Jingyuan Huang, Haili Wang, Lu Li, Haigang Lv
Products/Services Used Details Operation
Plasmid DNA Preparation … were determined by ELISA (all the kits were acquired from Dakewe Biotech Co., Ltd … 1: 1000, R&D Systems, MN, USA) and GAPDH (1: 1000, Santa Cruz Biotechnology Inc., CA … CHI3L1-3′UTR recombinant dual-luciferase reporter plasmids were acquired from GenScript Co., Ltd … Get A Quote

摘要

objective: Over the years, roles of microRNAs (miRNAs) in development of human diseases has been broadly investigated, while the role of dexmedetomidine (DEX) regulating miR-381-5p in myocardial ischemia-reperfusion injury (MIRI) remains largely unknown. Thus, we aimed to identify the effect of DEX on MIRI via mediating miR-381-5p. methods: The MIRI mice models were established by the ligation of the left anterior descending (LAD) artery and treated with miR-381-5p agomir, silenced chitinase-3-like 1 protein (CHI3L1) and DEX. The cardiac function, serum inflammatory factors, pathological changes and cardiomyocyte apoptosis of the mice' myocardial tissues were measured. The targeting relationship between miR-381... More

关键词

Chitinase-3-like 1 protein, Dexmedetomidine, Inflammatory response, MicroRNA-381-5p, Myocardial ischemia–reperfusion injury